Lv2
136 积分 2023-11-30 加入
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
1个月前
已关闭
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
1个月前
已完结
CAR-T for multiple myeloma: practice pearls
2个月前
已完结
Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm
2个月前
已完结
Senescence-resistant human mesenchymal progenitor cells counter aging in primates
2个月前
已完结
Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018
2个月前
已完结
Clinical, tumor and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma
3个月前
已完结
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
3个月前
已完结
Honing CAR T cells to tackle acute myeloid leukemia
3个月前
已完结
Interpreting the clinical outcomes to date for AML-directed CAR T cell therapies
3个月前
已完结
皖公网安备34019202002308
